HighTower Advisors’s Allogene Therapeutics ALLO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$32.8K Buy
+13,441
New +$26.9K ﹤0.01% 3737
2025
Q4
Sell
-11,740
Closed -$14.6K 3658
2025
Q3
$14.6K Sell
11,740
-410
-3% -$489 ﹤0.01% 3687
2025
Q2
$13.7K Hold
12,150
﹤0.01% 3626
2025
Q1
$17.7K Hold
12,150
﹤0.01% 3525
2024
Q4
$25.9K Sell
12,150
-17,500
-59% -$43.2K ﹤0.01% 3519
2024
Q3
$82K Sell
29,650
-906
-3% -$2.42K ﹤0.01% 3346
2024
Q2
$72K Hold
30,556
﹤0.01% 3261
2024
Q1
$137K Buy
30,556
+5,000
+20% +$20.9K ﹤0.01% 3079
2023
Q4
$82K Sell
25,556
-30,303
-54% -$85.9K ﹤0.01% 3235
2023
Q3
$176K Sell
55,859
-468
-0.8% -$2.05K ﹤0.01% 2950
2023
Q2
$279K Sell
56,327
-532
-0.9% -$2.88K ﹤0.01% 2611
2023
Q1
$280K Sell
56,859
-488
-0.9% -$3.13K ﹤0.01% 2507
2022
Q4
$361K Sell
57,347
-10,712
-16% -$99.2K ﹤0.01% 2344
2022
Q3
$734K Hold
68,059
﹤0.01% 1788
2022
Q2
$776K Buy
68,059
+17,500
+35% +$155K ﹤0.01% 1788
2022
Q1
$462K Sell
50,559
-30
-0.1% -$312 ﹤0.01% 2223
2021
Q4
$753K Sell
50,589
-1,220
-2% -$21.5K ﹤0.01% 1917
2021
Q3
$1.33M Buy
51,809
+5,500
+12% +$131K ﹤0.01% 1498
2021
Q2
$1.21M Sell
46,309
-2,000
-4% -$57K ﹤0.01% 1524
2021
Q1
$1.7M Hold
48,309
0.01% 1218
2020
Q4
$1.22M Buy
48,309
+3,850
+9% +$125K 0.01% 1162
2020
Q3
$1.68M Sell
44,459
-1,826
-4% -$68.8K 0.01% 954
2020
Q2
$1.98M Sell
46,285
-10,160
-18% -$367K 0.01% 805
2020
Q1
$1.1M Buy
+56,445
New +$1.34M 0.01% 962
2019
Q4
Sell
-23,140
Closed -$630K 2310
2019
Q3
$630K Buy
23,140
+11,738
+103% +$334K ﹤0.01% 1397
2019
Q2
$306K Buy
+11,402
New +$318K ﹤0.01% 1792

Other funds holding ALLO